All In Biotech

Drug Trial Radar · NCT07331818

Luspatercept in Patients Affected With Rare Inherited Anemias

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

45

Planned (sponsor's estimate)

Start

Mar 17, 2026

Primary completion

Sep 2028

Study completion Sep 30, 2029

Sponsor

Lead sponsor
EuroBloodNet AssociationAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective multicenter phase II basket trial evaluating Luspatercept in patients affected with rare inherited anemias

Conditions

  • Hereditary Red Blood Cell Disorder (Disorder)

Interventions

  • ReblozylDrug

    Reblozyl 25 mg powder for solution for injection / Reblozyl 75 mg powder for solution for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluating Luspatercept in patients affected with rare inherited anemias - Transfusion dependent patientsTime frame: Up to 52 weeks
  2. Evaluating Luspatercept in patients affected with rare inherited anemias - Non Transfusion dependent patientsTime frame: Up to 52 weeks

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • GCS Groupement des Hôpitaux de l'Institut Catholique de Lille

    Lille, France · Recruiting

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, France · Recruiting

  • Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis

    Paris, France · Recruiting

  • Assistance Publique Hôpitaux de Paris - Hôpital Necker

    Paris, France · Recruiting

  • CHU Bordeaux-Hôpital Haut-Lévêque

    Pessac, France · Recruiting

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano

    Milan, Italy · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.